Publications by authors named "V Gressin"
Advances in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) over the past decade changed the disease landscape, yet global insight on clinical practices remains limited. The CTEPH global cross-sectional scientific survey (CLARITY) aimed to gather information on the current diagnosis, treatment, and management of CTEPH and to identify unmet medical needs. This paper focuses on the treatment and management of CTEPH patients.
View Article and Find Full Text PDFEarly recognition and diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is crucial for improving prognosis and reducing the disease burden. Established clinical practice guidelines describe interventions for the diagnosis and evaluation of CTEPH, yet limited insight remains into clinical practice variation and barriers to care. The CTEPH global cross-sectional scientific survey (CLARITY) was developed to gather insights into the current diagnosis, treatment, and management of CTEPH and to identify unmet medical needs.
View Article and Find Full Text PDFArticle Synopsis
- The text discusses an error found in a figure that is part of a larger document or research paper. !*
- The error may impact the interpretation of data or findings presented in the document. !*
- The author likely calls for attention to the mistake, possibly indicating a need for correction or clarification. !*
Article Synopsis
- This analysis explored how hospitalizations impact the survival of patients with chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic, focusing on data from 2003 to 2016.
- It found that a first hospitalization due to CTEPH is a significant predictor of increased mortality, especially in patients who are not eligible for pulmonary endarterectomy (PEA), showing nearly double the risk of death.
- The study suggests that inoperable CTEPH patients may benefit from additional medical or interventional treatments based on their hospitalization history.
Article Synopsis
- This study analyzed the occurrence and survival rates of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic from 2003 to 2016, focusing on patients who were treated with pulmonary endarterectomy (PEA).
- Out of 453 patients diagnosed, about 52.1% had PEA surgery, but 34.1% of those still suffered from residual pulmonary hypertension afterward.
- The findings showed a CTEPH incidence rate of 4.47 patients per million per year, with an overall median survival of 11.2 years after diagnosis, highlighting significant differences in survival between operated patients and those who did not undergo surgery.